Jun 21, 2021 / 01:20PM GMT
Elliott Beilin - Raymond James Financial, Inc. - Analyst
Good morning, everyone, and thank you very much for joining the Human Health Innovation Conference at Raymond James. With us today, we have Anthony Kim, Chief Finance Officer at Marker Therapeutics, who will be giving the presentation today. And after the presentation, we will break out into a quick Q&A session, where I will read out all questions received during the call. And with that, I will turn it over to Anthony.
Anthony Kim - Marker Therapeutics, Inc. - CFO
Thank you for joining us for our corporate presentation here today. I am Tony Kim, the CFO for Marker Therapeutics. On behalf of my colleagues, I would like to thank the Raymond James team for inviting us here for this conference.
As a reminder, we are a public company and we'll be making forward-looking statements. These statements are subject to risks and uncertainties that may cause actual results to differ from forecasted. A description of these risks can be found in our most recent Form 10-Q and 10-K on file with the SEC.
Marker Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
